Bibliography
- Fan AC , Deb-BasuD, OrbanMWet al.: Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.Nat. Med.15, 566–571 (2009).
- Lymph Node Pathology (4th Edition). IoachimHL, MedeiorisLJ (Eds). Walters Kulwer/Lippincott Williams & Wilkins, NY, USA21–31 (2009).
- WHO Classification of Tumours of Hematopoietic Tissue. SwerdlowSH, CampoE, HarrisNLet al. (Eds). IARC, Lyon, France32–39; 262–266 (2008).
- Deng X , KornblauS, RuvoloPPet al.: Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistence.J. Nat. Cancer Inst. Mon.28, 30–36 (2000).
- Dave SS , FuK, WrightGWet al.: Molecular diagnosis of Burkitt’s lymphoma.N. Engl. J. Med.354, 2431–2442 (2006).
- Rosenwald A , WrightG, ChanWCet al.: The usage of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.N. Engl. J. Med.346, 1937–1947 (2002).
- Ajith TA , AnuV, RijiT: Antitumor and apoptosis promoting properties of atrovastastin, an inhibitor of HMG-CoA reductase, against Dalton’s lymphoma ascites in mice.J. Exp. Ther. Oncol.7, 291–298 (2008).
- Cappo P , Dusanter-FourtI, MillotGet al.: Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.Oncogene22, 4102–4110 (2002).
- Cappo P , FlamantS, De MasVet al.: BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.Brit. J. Haemtol.134, 171–179 (2006).
- Cappo P , Dustaner-FourtI, VanichenkerWet al.: BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levels.Cell Signal.21, 52–60 (2009).